معرفی
Dr. Lynnette A. Averill is an Adjunct Professor of Psychiatry at Yale School of Medicine, specializing in translational clinical neuroscience with a focus on PTSD, suicidality, and trauma-related psychopathology. Her work emphasizes pharmacoimaging trials evaluating glutamatergic drugs like ketamine for suicidal ideation and cognitive function. She is affiliated with the Emerge Research Program and holds editorial roles in journals like Chronic Stress and Clinician's Trauma Update.
Education & Training:
- PhD in Clinical Psychology, University of Utah (2013)
- Postdoc at National Center for PTSD, VA Connecticut (2015)
- Fulbright Scholar at Phoenix Australia (2009)
Research Focus:
Her research integrates neuroimaging, pharmacology, and clinical trials to understand brain mechanisms underlying PTSD and suicide risk. Key areas include:
- Ketamine's rapid antidepressant effects
- Synaptic connectivity alterations in trauma disorders
- Psychedelic-assisted therapies
- Early life trauma's neurobiological impacts
Recent Article Trends:
2023-2025 publications emphasize:
- Psychedelic medicine ethics and clinical applications
- Neurotransmitter abnormalities in PTSD
- Ketamine's role across mood and trauma disorders
- Veteran-specific trauma interventions
Awards & Recognition:
- 2016 NARSAD Young Investigator Award
- 2017 AFSP Young Investigator Award
- VA Career Development Honors (2016)
- Multiple editorial leadership roles
Grants & Trials:
Leading trials on:
- Ketamine's antidepressant mechanisms
- Psychedelic therapies for co-occurring disorders
- Stress biomarker identification
Labs & Teams:
Primary affiliation with the Emerge Research Program focusing on innovative PTSD treatments and brain imaging studies.
